ALS Investment Fund
hybrid fundWebsite
Fund rating
0.0 / 35
0 published reviews
No per-dimension scores yet.
Published reviews
About
A for-profit venture capital firm accelerating treatments for ALS and related neurodegenerative diseases; the platform could support cell-type-specific drug-response and repurposing research relevant to neurodegeneration.